Ahmed Farag Elhassanien, Abdel-Aziz Alghaiaty Hesham, Fawaz AlrefaeeRisk Manag. Fever without source in infants and young children: dilemma in diagnosis and management // Healthc Policy. 2013; 6: 7–12.
А.А. Баранов, В.К. Таточенко, М.Д. Бакрадзе. Лихорадочные синдромы у детей. Рекомендации по диагностике и лечению. М., 2011, 211 стр.
Baraff LJ. Management of infants and young children with fever without source // Pediatr Ann. 2008 Oct;37(10):673-9.
Kamalpreet Kaur, Rajiv Mahajan, Aparna Tanwar. A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting // Int J Appl Basic Med Res. 2013 Jul-Dec; 3(2): 77–83.
Manzano S, Bailey B, Girodias JB et al. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial // Am J Emerg Med . 2010;28:647–653.
Galetto-Lacour A , Zamora SA , Andreola B , et al. Validation of a laboratory risk index score for the identification of severe bacterial infection in children with fever without source // Arch Dis Child . 2010;95:968–973.
Baskin M., O’Rurcke E., Fleisher G. Outpatient treatment of febrile infants 28-90 days of age with intramuscular ceftriaxone // J. Ped. – 1992; 120:22-27.
Bass J.W., Steele R.W., Witter R.R. et al. Antimicrobal treatment of occult bacteriemiai^ a multicentre cooperative study // Pediatr. Infect. Dis. J. – 1993; 12: 466.
Department for Health and Ageing, Government of South Australia. Clinical Guideline Management of Fever without Focus in Children (excluding neonates), 2013, 13 стр.
American College of Emergency Physicians Clinical Policies Committee, American College of Emergency Physicians Clinical Policies Subcommittee on Pediatric Fever Clinical policy for children younger than three years presenting to the emergency department with fever // Ann Emerg Med. 2003;42(4):530–545.
Yo CH, Hsieh PS, Lee SH, Wu JY, Chang SS, Tasi KC, Lee CC. Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis // Ann Emerg Med. 2012 Nov;60(5):591-600.
Colvin JM, Muenzer JT, Jaffe DM, Smason A, Deych E, Shannon WD, Arens MQ, Buller RS, Lee WM, Weinstock EJ, Weinstock GM, Storch GA. Detection of viruses in young children with fever without an apparent source // Pediatrics. 2012 Dec;130(6):e1455-62.
Quenot JP, Luyt CE, Roche N, Chalumeau M, Charles PE, Claessens YE, Lasocki S, Bedos JP, Péan Y, Philippart F, Ruiz S, Gras-Leguen C, Dupuy AM,Pugin J, Stahl JP, Misset B, Gauzit R, Brun-Buisson C. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy // Ann Intensive Care. 2013 Jul 8;3(1):21.
Baraff L.J. Oslund S., Prathe M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteriemia // Pediatrics. – 1993; 92: 140.
Bulloch B. et al. The use of antibiotics to prevent serious sequelae in children at risk for occult bacteriemia: a meta-analysis // Acad. Emerg. Med. – 1997; 4: 679.
Rothrock S. et al. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteriemia? A meta-analysis // Pesiatr. Inf. Dis. J / 2005; 24 (1): 10-17.
Mistry RD, Wedin T, Balamuth F, McGowan KL, Ellison AM, Nelson KA, McLoughlin RJ, Alpern ER. Emergency Department Epidemiology of Pneumococcal Bacteremia in Children Since the Institution of Widespread PCV7 Vaccination // J Emerg Med. 2013 Dec;45(6):813-20. doi: 10.1016/j.jemermed.2013.04.029.